This is to inform the exchange that the meeting of Board of Directors of the M/s. Bacil Pharma Limited has been duly convened on Tuesday 15th day of September 2020 at the registered office of the Company. The Board transacted following items:
Approved and adopted the un-audited Financial Results of the Company for the Quarter ended 30th June 2020.
Approved Limited Review Report for the Quarter ended 30th June 2020.
Bacil Pharma: Outcome Of Board Meeting Held On 15Th September 2020
15-Sep-2020
Download PDF
Bacil Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month